Oneness Biotech Co Stock Net Asset
| 4743 Stock | TWD 107.00 5.50 5.42% |
Oneness Biotech Co fundamentals help investors to digest information that contributes to Oneness Biotech's financial success or failures. It also enables traders to predict the movement of Oneness Stock. The fundamental analysis module provides a way to measure Oneness Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oneness Biotech stock.
Oneness |
Oneness Biotech Co Company Net Asset Analysis
Oneness Biotech's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Oneness Biotech Net Asset | 15.73 B |
Most of Oneness Biotech's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oneness Biotech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Oneness Biotech Co has a Net Asset of 15.73 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net asset for all Taiwan stocks is notably lower than that of the firm.
Oneness Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oneness Biotech's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oneness Biotech could also be used in its relative valuation, which is a method of valuing Oneness Biotech by comparing valuation metrics of similar companies.Oneness Biotech is currently under evaluation in net asset category among its peers.
Oneness Fundamentals
| Return On Equity | 0.0788 | |||
| Return On Asset | -0.0068 | |||
| Profit Margin | 1.06 % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 92.26 B | |||
| Shares Outstanding | 387.86 M | |||
| Shares Owned By Insiders | 30.64 % | |||
| Shares Owned By Institutions | 14.80 % | |||
| Price To Book | 6.54 X | |||
| Price To Sales | 88.17 X | |||
| Revenue | 65.77 M | |||
| Gross Profit | 45.04 M | |||
| EBITDA | (193.72 M) | |||
| Net Income | (403.3 M) | |||
| Book Value Per Share | 39.63 X | |||
| Cash Flow From Operations | (288.89 M) | |||
| Earnings Per Share | 2.79 X | |||
| Number Of Employees | 20 | |||
| Beta | 1.65 | |||
| Market Capitalization | 105.11 B | |||
| Total Asset | 15.73 B | |||
| Net Asset | 15.73 B |
About Oneness Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oneness Biotech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oneness Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oneness Biotech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Oneness Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oneness Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oneness Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Oneness Stock
Moving against Oneness Stock
| 0.87 | 2891 | CTBC Financial Holding | PairCorr |
| 0.82 | 2891B | CTBC Financial Holding | PairCorr |
| 0.74 | 2883 | China Development | PairCorr |
| 0.69 | 4162 | PharmaEngine | PairCorr |
| 0.56 | 2330 | Taiwan Semiconductor | PairCorr |
The ability to find closely correlated positions to Oneness Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oneness Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oneness Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oneness Biotech Co to buy it.
The correlation of Oneness Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oneness Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oneness Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oneness Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.